.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

US Army
Accenture
Merck
Moodys
AstraZeneca
Fish and Richardson
Queensland Health
Farmers Insurance
Covington
Chinese Patent Office

Generated: June 25, 2017

DrugPatentWatch Database Preview

BAYCOL Drug Profile

« Back to Dashboard

What is the patent landscape for Baycol, and when can generic versions of Baycol launch?

Baycol is a drug marketed by Bayer Pharms and is included in one NDA.

The generic ingredient in BAYCOL is cerivastatin sodium. Additional details are available on the cerivastatin sodium profile page.

Summary for Tradename: BAYCOL

Patents:0
Applicants:1
NDAs:1
Bulk Api Vendors: see list31
Patent Applications: see list2,238
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:BAYCOL at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-001Jun 26, 1997DISCNNoNo► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-004Jun 26, 1997DISCNNoNo► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-002Jun 26, 1997DISCNNoNo► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-003Jun 26, 1997DISCNNoNo► Subscribe► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-006Jul 24, 2000DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: BAYCOL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-002Jun 26, 19975,177,080► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-003Jun 26, 19975,177,080► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-004Jun 26, 19975,006,530► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-001Jun 26, 19975,006,530► Subscribe
Bayer Pharms
BAYCOL
cerivastatin sodium
TABLET;ORAL020740-003Jun 26, 19975,006,530► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Cantor Fitzgerald
Medtronic
Fuji
Argus Health
McKesson
QuintilesIMS
Mallinckrodt
Baxter
Chubb
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot